Research

Hormonal

SGLT2 inhibitors improve vascular function by reducing arterial stiffness, improving endothelial function (flow-mediated dilation), and reducing inflammation and oxidative stress.

These drugs don't just lower sugar; they physically improve the health of your blood vessels by making them more flexible and reducing the chemical stress (inflammation/oxidative stress) that damages them over time.

GoodSupportsHIGH confidence
SGLT2 inhibition has been shown to improve arterial stiffness... SGLT2 inhibitors reduce vascular inflammation... SGLT2 inhibition has been shown to reduce leukocyte mitochondrial superoxide production... The DEFENCE trial showed that 16 weeks of dapagliflozin reduced urine 8-hydroxy-2′-deoxyguanosine (8-OHdG), a marker of oxidative stress.
Ying Jie Chee et al. · Biomedicines · 2024

Why this rating

Supported by multiple meta-analyses and RCTs (DEFENCE, etc.), though some markers (CRP) show mixed results.

Source

Novel Therapeutics for Type 2 Diabetes Mellitus—A Look at the Past Decade and a Glimpse into the Future

Ying Jie Chee et al. · Biomedicines · 2024

DOI 10.3390/biomedicines12071386

narrative_reviewCited 6×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →